Similar articles

• Prolactinomas in women: current therapies.

  Robinson AG, Nelson PB. Robinson AG, et al. Ann Intern Med. 1983 Jul;99(1):115-8. doi: 10.7326/0003-4819-99-1-115. Ann Intern Med. 1983. PMID: 6344716 Review. No abstract available.
• Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.

  Hancock KW, Scott JS, Lamb JT, Gibson RM, Chapman C. Hancock KW, et al. Br Med J (Clin Res Ed). 1985 Jan 12;290(6462):117-8. doi: 10.1136/bmj.290.6462.117-a. Br Med J (Clin Res Ed). 1985. PMID: 3917709 Free PMC article. No abstract available.
• Relationship between the methods of treatment for prolactinomas and the puerperal lactation.

  Ikegami H, Aono T, Koizumi K, Koike K, Fukui H, Tanizawa O. Ikegami H, et al. Fertil Steril. 1987 May;47(5):867-9. doi: 10.1016/s0015-0282(16)59182-1. Fertil Steril. 1987. PMID: 3569564 No abstract available.
• Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?

  Landolt AM, Keller PJ, Froesch ER, Mueller J. Landolt AM, et al. Lancet. 1982 Sep 18;2(8299):657-8. doi: 10.1016/s0140-6736(82)92756-8. Lancet. 1982. PMID: 6125789 No abstract available.
• Prolactin-producing pituitary tumors: medical therapy.

  Vaughn TC, Hammond CB. Vaughn TC, et al. Clin Obstet Gynecol. 1980 Jun;23(2):403-11. doi: 10.1097/00003081-198006000-00010. Clin Obstet Gynecol. 1980. PMID: 6994967 Review.